Market Research Blog

The global Canine Arthritis Treatment Market stands at a net worth of US$ 2.39 Bn in 2022. Worldwide demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.2% and attain a market valuation of US$ 3.05 Bn by 2028. Canine arthritis treatment medicines accounted for 17.2% share of the global rare inflammatory disease treatment market in 2021.

Canine arthritis is a degenerative joint disease that produces inflammation in the joints of dogs as a result of frequent rubbing, cartilage degradation, and long-term joint disease. The knees, elbows, shoulders, hips, and spinal cord are usually the most affected joints in animals. Injuries, overweight, and faulty bone formation are some of the reasons for canine arthritis in dogs.

A notable increase in dog ownership around the world, developing veterinary healthcare infrastructure and rising treatment options for canine arthritis are the key factors for the growth of the global canine arthritis treatment market.

As per the findings of Future Market Insights, the global canine arthritis treatment market is projected to experience significant growth during the forecast period, due to increasing prevalence of obesity induced arthritis among dogs and rise in awareness about the companion animal health. Moreover, ease in the FDA approval for novel and innovative canine arthritis treatment drugs will create growth opportunities for the market players.

The global canine arthritis treatment market valued in 2019 is estimated at ~ US$ 1.9 Bn, and is expected to increase at a CAGR of ~ 4% during the forecast period of 2019-2029.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-3552

Key Takeaways from Canine Arthritis Treatment Market Study

• Non-steroidal anti-inflammatory medications are referred as a first choice of veterinarian for the treatment of inflammation and pain. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling, and pain. Canines approved non-steroidal anti-inflammatory medications have demonstrated acceptable safety profile, which is in contrast to non-approved NSAIDs.
• Growth prospects of the canine arthritis market are relatively high in North America as compared to other regions, attributed to rise in the adoption rate of canines, increasing veterinary expenditure on their health, and greater awareness about the pet health.
• Market players remained focused on capitalizing on veterinary hospitals and clinics, as they provide an entire animal care and service support for better pet health.
• Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.

Robust Clinical Development Pipeline to Dictate Stakeholders’ Strategies

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.

Key Segments Of Canine Arthritis Treatment Industry Survey

Canine Arthritis Treatment Market by Treatment:

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

Canine Arthritis Treatment Market by Route of Administration:

• Oral Canine Arthritis Treatment
• Injectable Canine Arthritis Treatment

Canine Arthritis Treatment Market by Distribution Channel:

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Drug Stores
• e-Commerce

Canine Arthritis Treatment Market by Region:

• North America Canine Arthritis Treatment Market
• Latin America Canine Arthritis Treatment Market
• Europe Canine Arthritis Treatment Market
• East Asia Canine Arthritis Treatment Market
• South Asia & Pacific Canine Arthritis Treatment Market
• Middle East & Africa (MEA) Canine Arthritis Treatment Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3552

Table of Content

1. Executive Summary

1.1. Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity Analysis

3.1.4. Trends

4. Market Context

4.1. Global Healthcare Market Outlook

4.2. Global Canine Arthritis Treatment Scenario

4.3. Pet Ownership in European Union (EU)

4.4. Share of Household Owing at least one Dog in European Union (EU)

4.5. Spending on Health of Pets

4.6. Vet care Spending on Dogs

4.7. Key Regulations and Guidelines

5. Global Canine Arthritis Treatment Market (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028

5.1. Historical Market Value (US$ Mn) Analysis, 2013-2021

5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.2.3. Market Value Comparison

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3552

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Rising prevalence of cancer is likely to fuel the demand for cancer diagnostics. A study by Future Market Insights (FMI) projects the cancer diagnostics market to surpass US$ 47.62 Bn in 2021. According to the World Health Organization (WHO), cancer is the second -leading cause of death globally, accounting for over 9.9 million deaths in 2020. Rising cases of cancer have been fuelling the demand for advanced diagnostics.

Technological advancements in various fields such as biopsy, imaging, biomarkers and endoscopy, rising prevalence of cancer, increase in government initiatives for creating awareness, rapidly increase in geriatric population, and growing government funding are key factors driving the growth of the cancer diagnostics market.

Timely detection of cancer requires suitable diagnostic tests to screen the immunosuppressed population which is at moderate risk of cancer, particularly for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer and melanoma. Growing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among the general population supplements the growth of cancer diagnostics.

Inclusion of cancer screening tests in National Cancer Screening Programs is another major factor expected to fuel the demand for cancer diagnostics. Introduction of regular mammography into national cancer programs by major developed countries where the incidence of breast cancer is high that is leading towards increasing adoption of cancer diagnostics in developed region.

For instance, the U.S. government has included the National Mammography Program in its national cancer screening programs. The government of Australia is taking initiative by conducting 3 cancer screening programs such as the National Cervical Screening Program, BreastScreen Australia and the National Bowel Cancer Screening Program. Similarly, most of the countries in Europe are continuously adopting HPV DNA screening for cervical cancer as a part of national cervical cancer programs.

Short-term Negative Impact Likely Due to COVID-19

The cancer diagnostics market is expected to experience short-term negative growth owing to a reduction in the cancer diagnosis procedures and adoption rate in developed and emerging countries. COVID-19 has impacted the landscape of cancer diagnostics. This has affected demand in various fronts, from prevention to screening and diagnosis, palliative care, treatment, and patient follow-up, to logistics and supplies of cancer diagnostic tests kits and other essential commodities.

Nonetheless after a period of muted growth, the market is poised to recover as economies return to normalcy. As per FMI, the rising incidence of lung cancer is attributable for over 19% of sales in the market.

Key Takeaways from Cancer Diagnostics Market Study

• The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022
• Increasing cases of cancer in the U.S. accounts for 84% of demand in North America
• Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021
• Favorable reimbursement policies will support growth in France and Germany
• Expansion of the healthcare sector will support growth in Japan and South Korea

“Advancements in cancer diagnostics and rising prevalence of cancer are expected to aid growth of cancer diagnostics. A majority of leading players in cancer diagnostic market are adopting strategic partnerships to sustain the increasing competitive pressure,” says the FMI Analyst

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-1090

Who is Winning?

Partnerships between cancer diagnostic assay kits developers, instrument manufacturers and technology licensers are often intended to increase the consumer base.

For instance, in March 2021, Illumina, Inc. signed a partnership agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits by using Illumina’s NextSeq 550Dx sequencing platform for cancer.

In June 2020, Thermo Fisher Scientific signed an agreement with Daiichi Sankyo to Co-launch a companion diagnostic for patients with non-small cell lung cancer for identifying Her2 gene mutations using the Oncomine Dx target test.

Cancer Diagnostics Market by Category

Test Type

• Tumour Biomarkers Tests
  • PSA Tests
  • CTC Tests
  • AFP Tests
  • CA Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • CEA Tests
  • EGFR Mutation Tests
  • KRAS Mutation Tests
  • Others
• Imaging
  • Ultrasound
  • Mammography
  • MRI Scan
  • PET Scan
  • CT Scan
  • SPECT & Others
• Biopsy
  • Needle Biopsy
  • Endoscopic Biopsy
  • Bone Marrow Biopsy
  • Others
• Liquid Biopsy
• Immunohistochemistry
• In Situ Hybridization

Indication

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Blood Cancer
• Prostate Cancer
• Ovarian Cancer
• Stomach Cancer
• Liver Cancer
• Others

End-user

• Hospital Associated Labs
• Independent Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Others

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1090

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Market Dynamics

2.4. Inclusions and Exclusions

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Global GDP Growth Outlook

3.1.2. Global Healthcare Expenditure Outlook

3.1.3. Growth of Healthcare Sector in Emerging Nations

3.2. Forecast Factors – Relevance & Impact

3.2.1. Global Increase in Healthcare Expenditure

3.2.2. Rising Prevalence of Cancer

3.2.3. Changing Regulatory Dynamics

3.2.4. Cost Impact

3.2.5. Regulatory Scenario

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunity Analysis

4. Market Context

4.1. Key Industry Developments

4.2. Disease Epidemiology

4.3. Regulatory and Reimbursement Scenario

4.4. Strategic Promotional Strategies by Manufacturer

5. COVID19 Crisis Impact Analysis

5.1.1. Current perspectives on the Coronavirus outbreak

5.1.2. Current GDP Projection and Probable Impact

5.1.3. Current Economic Projection as compared to 2008 Economic analysis

5.1.4. COVID19 and Impact Analysis

5.2. Cancer Diagnostics Market Revenue Impact Analysis

5.2.1. Historical (pre-COVID), Current (during-COVID), Future (post-COVID)

5.2.1.1. By Test Type

5.2.1.2. By Indication

5.2.1.3. By End User

5.2.1.4. By Region

5.2.2. 2020 Market Scenario

5.3. Impact on Trends Analysis

5.4. Recovery Scenario – Short term, Midterm and Long Term Impact

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-1090

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

As per the study, the global automated CPR devices market is slated to grow at approximately 13% CAGR throughout the forecast period from 2021 to 2031.

The market is anticipated to grow significantly over the forthcoming decade, as majority of coronary and intensive care units are inclining towards automated CPR devices for its high effectiveness.

The demand for automated CPR devices has been increasing significantly with rising prevalence of sudden cardiac arrest across the globe, according to ESOMAR-certified Future Market Insights’ (FMI) latest research reportMajor progress has been witnessed with 3D automatic CPR devices, especially when normal CPR device coupled with torso restraints providing vertical compression and high quality resuscitation.

Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest.

 “Rising consumer awareness regarding benefits of CPR devices and increasing adoption in EMT services will amplify sales of automated CPR devices during the forecast period,” says the FMI analyst.

Key Takeaways from FMI’s Automated CPR Devices Market Study

• Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S.
• The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases.
• Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France.
• China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure.
• India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country.

Competitive Landscape

Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence.

For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions.

ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-720

Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc.

In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa

Key Segments Covered

By Power Source

• Pneumatically Driven CPR Devices
• Battery Driven CPR Devices
• Mechanically Actuated And Battery Driven CPR Device

By Device Type

• Piston Devices
• Load Distribution Devices
• 3D Compression Devices

By End User

• EMS
• Hospitals
• Ambulances
• Coronary & Intensive Care Units
• Cardiac Catheterization Labs
• Air Med-Evac Units
• EMT Rescue Units
• Others

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-720

Table of Content

1. Executive Summary
2. Research Methodology
3. Assumptions & Acronyms Used
4. Market Overview

4.1. Introduction

4.2. Market Definition

4.3. Comparison Between CPR Models – Technological Differentiation with reference to Operation

4.4. Comparison Between CPR Models – Technological Differentiation with reference to Operation

4.5. Comparative Impact Analysis of Load Distributing Band V/s Piston Driven Systems (Autopulse V/s Lucas 2)

5. Automated CPR Devices Market Forecast

5.1. Absolute $ Opportunity

5.2. Y-o-Y Growth Projections

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Inhibitors

5.3.3. Opportunities

5.4. Market Trends

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-720

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls. Increasing focus on developing such smart shunt technology, is anticipated to prove favorable for the hydrocephalus shunt market—showcasing an otherwise sluggish landscape through the forecast period of 2018-2028, as per FMI’s analysis.

The research intelligence report offers a deep-dive view of the global hydrocephalus shunt market—predicted to expand at a rather sluggish rate of 2.3 percent, reaching a valuation of US$ 498.6 Mn in 2020.

“Stringent regulatory policies is a key factor severely impacting the growth of hydrocephalus shunt market. In addition, mechanical risks including leaks, migration, obstruction, and discontinuity and biological complications including infection, abscess, pseudocyst, heamotoma, and peritonitis associated with shunt implants, is also a key factor contributing to the market’s slow-moving growth. Other contributing factors could include high surgery costs and shortage of trained neurologist—specifically reported in countries like Australia, Canada, Ireland, U.K, and New”, explains a senior analyst from the Healthcare domain. The analyst further explains that shunt blockage and malfunction are two common complication associated with stunt implants—blockages occurring in nearly 31 percent patients. Moreover, such risks and complications often result in a number of hydrocephalus shunt revision surgeries, further creating a notable demand for hydrocephalus shunt.

Hydrocephalus Shunt Market

FMI offers key insights on the global hydrocephalus shunt market

• Hydrocephalus valves segment is expected to hold a massive value share of nearly 85 percent.
• Within the Hydrocephalus valves type, adjustable pressure valves is likely to witness maximum adoption in hydrocephalus shunt surgeries.
• Highest growth potential exists in North America, with an attractiveness index of 2.6 during the forecast period. Such adoption trend is expected to be followed in Western Europe—the second most lucrative market, showcasing interesting profit possibilities.
• By age group, pediatrics and infants segment will report maximum adoption of hydrocephalus shunt.
• Ventriculoperitoneal will remain the most preferred procedure, pushing maximum revenue in the global hydrocephalus shunt.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-7756

Key Market Influencers: Technological Advancements and Awareness Campaigns for Hydrocephalus

Considering the complexity of hydrocephalus shunting along with adjustments of cerebrospinal fluid draining, manufacturers of hydrocephalus shunts are increasingly introducing programmable and anti-siphon shunt valves—aimed at regulating drainage pressure and flow. The new technologies are indicated to eliminate the need for surgery revisions as a result of complications. The cerebrospinal fluid management technologies are likely to witness increased adoption in the coming years considering its utility in reducing siphon effect over cerebrospinal fluid drainage. Programmable pressure valves are gaining prominence versus fix pressure valves owing to its external features using specialized magnetic devices that helps in modifying opening pressure of valves.

Additionally, demand for hydrocephalus shunts is slated to increase given the increasing number of government and private initiatives to spread awareness vis-à-vis hydrocephalus. Hydrocephalus Association, for instance, and its focus to conduct more hydrocephalus awareness campaigns and programs, with increased investments in research initiatives targeted at improving cure and treatment avenues for Hydrocephalus. Through its campaign ‘Roadmap to a Cure’, the organization, by 2020 is expected to invest US$20 and drive more research and support associated with hydrocephalus.

In the highly consolidated hydrocephalus shunt market, product and pricing power lies in the hand of top three players—reigning over nearly 84 percent of the total revenue share in the global hydrocephalus shunt market. Contributing nearly US$ 389 Million, the top three players include Medtronic Plc., Integra LifeSciences Corporation, and B. Braun Melsungen AG. Key forward market strategies include- viz. Efforts to gain regulatory approvals, geographic expansions in emerging economies, production capacity expansion, increased investments in R&D, and acquisitions to solidify global position in neurosurgery and regenerative technologies. Strategic collaborations in the form of mergers and acquisitions, is expected to bring significant growth opportunities for the three leading players, predicts FMI in its hydrocephalus shunt market report.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-7756

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Hydrocephalus Shunt Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Trends

5. Key Inclusions

5.1. Regulatory Scenario

5.2. Reimbursement Scenario

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-7756

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to the market projections given in the report, global genital herpes treatment market is expected to surge and reach a market size of over US$ 2881.8 Mn by the end of 2031. The market is expected to register a CAGR of 4.5% of during the forecast period of 2021-2031.

Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially.

With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2.

The market growth is primarily driven by the increase government spending on healthcare industry. Various countries are focused on prevention of infectious diseases which in turn, has a positive impact over the herpes drugs market leading to its high demand from local governments and third-party payers.

Global Genital Herpes Treatment Market: Trends and Opportunities

The global genital herpes treatment market may witness new opportunities in the market.  Globally, the increasing disease burden of herpes continuously provides an opportunity for the diagnostic and treatment market.

According to WHO, in 2016 around 67% of the world population (3.7 Bn) under the age of 50 were suffering from HSV-1 infection. This represents substantial growth of the global HSV disease treatment market over the forecast period. Similarly around 13% of the world population (491 Mn) under the age of 50 is living with HSV-2 infection as of 2016.

The companies are also trying to introduce cost effective treatment methods. New vaccines provide complete protection against a variety of strains of HSV1 and HSV2. Companies are increasing research and development activities for the treatment and prevention of genital herpes diseases. Most of the companies are focusing on approval and launch of generic drugs in the undeveloped countries to provide low cost drugs for the treatment of genital herpes.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-1390

Global Genital Herpes Treatment Market: Key Highlights from the Segmental Analysis

MEA is expected to come up as the most lucrative region in the industry. With the rise in sexually transmitted diseases in the region, the demand for genital herpes treatment is also expected to rise.

Regional analysis shows that MEA will witness a robust CAGR of 5.2% during the forecast period in the global genital herpes treatment market.  Based on the route of administration oral is the main segment, with the highest growth rate and highest market share in the global genital herpes treatment market.

Amongst various distribution channels, retail pharmacies hold the highest market size, but the segment lags behind in terms of growth rate. With the growth of online marketing and e-commerce, online pharmacies is the fastest growing segment which is expected to register a growth rate of 5.4% during the forecast period.

Global Genital Herpes Treatment Market: Top Companies

Some of the leading companies mentioned in the research report are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy’s Laboratories, ltd., Novartis AG, Valeant Pharmaceuticals International Inc., etc.

Key Segments Covered in Genital herpes treatment Market Study

Drug Type:

• Acyclovir
• Valacyclovir
• Famciclovir

Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

Route of Administration:

• Oral
• Topical
• Injectable

Indication:

• HSV-1
• HSV-2

Key Regions/Countries Covered:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific Ex. Japan (APEJ)
• Japan
• Middle East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1390

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Genital Herpes Treatment Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. North America Genital Herpes Treatment Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) By Drug Type 2012-2016

4.5.1. Acyclovir

4.5.2. Valacyclovir

4.5.3. Famciclovir

4.6. Market Size (US$ Mn) Forecast By Drug Type, 2017-2027

4.6.1. Acyclovir

4.6.2. Valacyclovir

4.6.3. Famciclovir

4.7. Historical Market Size (US$ Mn) By Route of Administration, 2012-2016

4.7.1. Oral

4.7.2. Topical

4.7.3. Injectable

4.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

4.8.1. Oral

4.8.2. Topical

4.8.3. Injectable

4.9. Historical Market Size (US$ Mn) By Indication, 2012-2016

4.9.1. HSV-1

4.9.2. HSV-2

4.10. Market Size (US$ Mn) Forecast By Indication, 2017-2027

4.10.1. HSV-1

4.10.2. HSV-2

4.11. Historical Market Size (US$ Mn) By Distribution Channel, 2012-2016

4.11.1. Hospital Pharmacies

4.11.2. Retail Pharmacies

4.11.3. Online Pharmacies

4.11.4. Drug Stores

4.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

4.12.1. Hospital Pharmacies

4.12.2. Retail Pharmacies

4.12.3. Online Pharmacies

4.12.4. Drug Stores

4.13. Drivers and Restraints: Impact Analysis

4.14. Market Attractiveness Analysis

4.14.1. By Country

4.14.2. By Drug Type

4.14.3. By Route of Administration

4.14.4. By Indication

4.14.5. By Distribution Channel

4.15. Key Representative Market Participants

4.16. Key Participants Market Presence (Intensity Map)

TOC Continued…!

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-1390

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

As per the latest market study by Future Market Insights (FMI), the global self-testing market  is projected to record a CAGR of 5.5% amid the forecast period, 2020-2030.

Consumers are swiftly adapting to buy self-testing kits due to early detection of severe allergies or diseases with the assistance of STI/STD self-tests, cancer-tests, and intolerance self-tests. Pharmacies are receiving a positive response online against the conventional approach of buying them from retail pharmacy stores subsequent to seeking medical advice. Market players are formulating these testing kits together with a range of wellness and prevention strategies, scoping from chronic disorder management and acute infection diagnoses to detecting probable risks of diseases.

Moreover, the COVID-19 outbreak and successive ripple effects have obliged retailers to shut down their stores, impacting the profit margins of self-testing kit producers. With brick-&-mortar stores closing down temporarily, players are placing their bets on e-commerce/online platforms to endure pandemic shockwaves.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7914

“Easy accessibility of product via online pharmacies or retail pharmacies is promising the producers to enter into an agreement with distribution and supply chain networks to enter untapped markets and establish a global footprint,” opines FMI analyst.

Self -Testing Market – Major Takeaways

• The global self testing market is forecasted to reach a valuation of US$ 11 Bn by 2030.
• By product, digital monitoring instruments will continue to be the preferred product category as they help care for ailments ranging from chronic to recovery conditions from acute episodes by gathering important patient data at-home settings.
• Based on the application, around 8 out of 10 users opt for utilizing these kits for testing blood glucose.
• Among distribution channels, the retail pharmacies will remain dominant attaining revenue close to US$ 3.5 Bn, by 2030.

Self -Testing Market – Key Drivers

• Demand for reliable and easy self-testing devices and kits has escalated owing to the fast generation of results along with maintaining the privacy.
• Easy accessibility and advertising schemes are influencing the self-testing market growth, optimistically.
• Growing awareness concerning healthcare and related ailments along with non-profit organizations and government’s encouragement complements the market growth.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-7914

Self -Testing Market – Regional Analysis

• North America remains the biggest market for self-testing kits, worldwide, trailed by Europe, due to mature healthcare infrastructure and favorable government policies.
• The European region is anticipated to be the second most lucrative region owing to the increasing occurrence of diabetics and the growing adoption rate.
• East Asia self-testing kits market is foreseeing huge demand, soaring investments in healthcare infrastructure up-gradation in addition to increasing trend of home diagnosis.

Self -Testing Market – Competitive Landscape

Market players extend to reap notable revenues from retail pharmacies. Conversely, they are additionally delving into new revenue streams in supermarkets/hypermarkets and online pharmacies. Prominent players operating in the global self-testing market include ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson & Company, Assure Tech (Hangzhou) Co. Ltd., Roche Holding AG, Bionime Corporation, True Diagnostics Inc., and Quidel Corporation.

Self- Testing Market – Taxonomy

Product

• Digital Monitoring Instruments
• Midstreams
• Cassettes
• Cups
• Strips
• Test Panels
• Dip Cards
• Others

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-7914

Application

• Pregnancy & Fertility Testing
• Blood Glucose Testing
• STD/ STI Testing
• Cancer Testing
• Cholesterol Testing
• Drug of Abuse Testing
• Thyroid Testing
• HIV Testing
• Others

Sample

• Blood
• Urine
• Stool
• Saliva
• Semen
• Vaginal Swab

Distribution Channel

• Drug Stores
• Retail Pharmacies
• Supermarket/Hypermarket
• Online Pharmacies

Regional Outlook:

• North America
• Latin America
• Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa (MEA)

Get Valuable Insights into the Self Testing Market

Future Market Insights, in its new offering, provides an unbiased analysis of the global self testing market, presenting historical demand data and forecast statistics for the period from 2020-2030. The study divulges compelling insights on the self testing market, allowing readers to glean qualitative and quantitative information which will enable them to make informed market decisions in the upcoming forecast period.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs